NEW YORK (GenomeWeb) – Human genetic variation can alter the efficacy of CRISPR targeting when it's used for therapeutic purposes, and increase the potential for off-target effects, according to the authors of a new study published yesterday in the Proceedings of the National Academy of Sciences.